Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder
Clinical trial NCT04753164 · COMPLETED
Trial details
- NCT number
- NCT04753164
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2022-03-21
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.